Inventor · disambiguated record
Nina Ha
Also filed as: HA NINA
7 granted patents·9 pending applications·11 citations·filing 2012–2023
74Inventor score
Top patents by PatentIndex Score
16 records- 0180US10287255B2Compounds as histone deacetylase 6 inhibitors and pharmaceutical compositions comprising the sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2015·Granted May 14, 2019·6 cites·8 claims
- 0272US9650379B2Azaindole derivatives as selective histone deacetylase (HDAC) inhibitors and pharmaceutical compositions comprising the sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2014·Granted May 16, 2017·4 cites·14 claims
- 0362US9878986B2Compounds for selective histone deacetylase inhibitors, and pharmaceutical composition comprising the sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2014·Granted Jan 30, 2018·1 cites·7 claims
- 0461US2025319093A1Compositions for preventing or treating idiopathic pulmonary fibrosis (ipf)CHONG KUN DANG PHARMACEUTICAL CORP·Filed 2023·Application pending·0 cites
- 0556US2024366623A1Compositions for preventing or treating charcot-marie-tooth disease (cmt)CHONG KUN DANG PHARMACEUTICAL CORP·Filed 2022·Application pending·0 cites
- 0650US2022008414A1Pharmaceutical composition comprising histone deacetylase 6 inhibitorsCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2019·Application pending·0 cites
- 0747US11571426B2Compositions for preventing or treating lupusCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2018·Granted Feb 7, 2023·0 cites·6 claims
- 0845US2023248735A1Compositions for preventing or treating chronic obstructive pulmonary diseases (copd)CHONG KUN DANG PHARMACEUTICAL CORP·Filed 2020·Application pending·0 cites
- 0943US2021077501A1Compositions for preventing or treating uveitisCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2019·Application pending·0 cites
- 1040US9447083B2N-acylhydrazone derivatives for selective T cell inhibitor and anti-lymphoid malignancy drugCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2013·Granted Sep 20, 2016·0 cites·8 claims
- 1139US2022296599A1Pharmaceutical composition comprising histone deacetylase inhibitor and methotrexateCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2019·Application pending·0 cites
- 1238US2014315889A1Hydroxamate derivatives for hdac inhibitor, and the pharmaceutical composition comprising thereofCHONG KUN DANG PHARM CORP·Filed 2012·Application pending·0 cites
- 1337US11420950B2Heterocyclicalkyl derivative compounds as selective histone deacetylase inhibitors and pharmaceutical compositions comprising the sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2016·Granted Aug 23, 2022·0 cites·6 claims
- 1437US2021161905A1Compositions for Preventing or Treating Dry EyeCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2019·Application pending·0 cites
- 1530US2016355475A1Novel indole derivative compound and pharmaceutical composition comprising the sameCHONG KUN DANG PHARMACEUTICAL CORP·Filed 2015·Application pending·0 cites
- 1628US9371294B2Cycloalkenyl aryl derivatives for CETP inhibitorLEE SEOHEE·Filed 2012·Granted Jun 21, 2016·0 cites·10 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →